glp 1 for 12 year olds GLP-1 prescribing among teens with obesity Wegovy for Teens: Girl, 16,

Fandio et al

Clinical Results for Retatrutide According to major foreign media outlets including The Guardian on June 8 local time, Lilly in March disclosed results from a Phase 3 clinical trial of retatrutide conducted over 40 weeks in 930 adults with type 2 diabetes

Furthermore, the Delphi statements and patient profiles predominantly focused on adults with normal or elevated BMI, reflecting the high prevalence of overweight/obesity in T2D and CKD

If you experience severe pain, persistent vomiting, or signs of an allergic reaction (like difficulty breathing or a rash), contact a healthcare provider immediately

This evolution in treatment highlights an urgent need for evidence that moves beyond weight loss alone to examine long-term cardiometabolic health, quality of life, and durability of treatment effects. Concerns about youth on GLP-1 According to Messiah, GLP-1 medications have demonstrated meaningful benefits for adolescents living with obesity, including substantial weight reduction and improvements in obesity-related conditions such as type 2 diabetes and hypertension, but she underscores that drugs need to be prescribed appropriately and accompanied by ongoing medical supervision